Evidence map›Paper›PMID 41405403›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

TBK1 Induces the Formation of Optineurin Filaments That Condensate with Polyubiquitin and LC3 for Cargo Sequestration.

Maria G Herrera, Lena Kühn, Lisa Jungbluth, Verian Bader, Laura J Krause, David Kartte, Elias Adriaenssens, Sascha Martens, Jörg Tatzelt, Carsten Sachse and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria G HerreraDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID https://orcid.org/0000-0002-8874-7410
Lena KühnDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
Lisa JungbluthErnst-Ruska Centre for Microscopy and Spectroscopy with Electrons, ER-C-3/Structural Biology, Forschungszentrum Jülich, 52425, Jülich, Germany.ORCID https://orcid.org/0000-0002-5295-0521
Verian BaderDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID https://orcid.org/0000-0001-5260-4728
Laura J KrauseDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
David KartteErnst-Ruska Centre for Microscopy and Spectroscopy with Electrons, ER-C-3/Structural Biology, Forschungszentrum Jülich, 52425, Jülich, Germany.
Elias AdriaenssensMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna, 1030, Austria.ORCID https://orcid.org/0000-0001-9430-917X
Sascha MartensMax Perutz Labs, Vienna Biocenter Campus (VBC), Vienna, 1030, Austria.ORCID https://orcid.org/0000-0003-3786-8199
Jörg TatzeltDepartment Biochemistry of Neurodegenerative Diseases, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID https://orcid.org/0000-0001-5017-5528
Carsten SachseErnst-Ruska Centre for Microscopy and Spectroscopy with Electrons, ER-C-3/Structural Biology, Forschungszentrum Jülich, 52425, Jülich, Germany.ORCID https://orcid.org/0000-0002-1168-5143
Konstanze F WinklhoferDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID https://orcid.org/0000-0002-7256-8231

Funding

Deutsche Forschungsgemeinschaft EXC 2033 - 390677874Deutsche Forschungsgemeinschaft FOR2848-401510699Deutsche Forschungsgemeinschaft RTG2862-492434978Deutsche Forschungsgemeinschaft SPP2453-541210481Helmholtz-Gemeinschaft KA1-Co-02 'CoViPa'Michael J. Fox Foundation for Parkinson's Research 021968
6 · The paper itself

Abstract

Optineurin is an autophagy receptor that plays an important role in the selective degradation of mitochondria, protein aggregates, and intracellular pathogens. It recognizes ubiquitylated cargo by its ubiquitin-binding in ABIN and NEMO (UBAN) domain and recruits the autophagic machinery through its LC3-interacting region (LIR) domain. Phosphorylation of Optineurin by TANK-binding kinase 1 (TBK1) increases the binding of Optineurin to both ubiquitin chains and lipidated microtubule-associated protein light chain 3 (LC3). Optineurin has been reported to form foci at ubiquitylated cargo, but the underlying mechanism and how these foci are linked to selective autophagy has remained largely unknown. This study shows that phosphorylation of Optineurin by TBK1 induces the formation of filaments that phase separate upon binding to linear polyubiquitin. LC3 anchored to unilamellar vesicles co-partitions into Optineurin/polyubiquitin condensates, resulting in the local deformation of the vesicle membrane. Thus, the condensation of filamentous Optineurin with ubiquitylated cargo promotes the nucleation of cargo and its subsequent alignment with LC3-positive nascent autophagosomes, suggesting that co-condensation processes ensure directionality in selective autophagy.

Indexed as

Microtubule-Associated ProteinsPolyubiquitinProtein Serine-Threonine KinasesTranscription Factor TFIIIAAutophagyCell Cycle ProteinsHeLa CellsHumansMembrane Transport ProteinsPhosphorylationCell Cycle ProteinsMAP1LC3A protein, humanMembrane Transport ProteinsMicrotubule-Associated ProteinsOPTN protein, humanPolyubiquitinProtein Serine-Threonine KinasesTBK1 protein, humanTranscription Factor TFIIIAautophagyOptineurinphase separationTBK1ubiquitin

Identifiers

PMID41405403
PMCPMC13042857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.